ProHealth health Resource
 SUBSCRIBE TO OUR FREE E-NEWSLETTERS  
Click Here to Preview
Log In
Catalog Quick Order
Your Account
Shopping Cart
 Check Out
ProHealth: News, Research, Vitamins & Supplements About ProHealth ProHealth ImmuneSupport.com ProHealth Online Vitamin & Supplement Store ProHealth Treatment & Research Library ProHealth Community ProHealth Vitamins & Supplements Catalog
Your Purchase Helps Fund Health Research
Explore Our Health Sites
ProHealth Vitamin and Supplement Catalog
Your resource for specialty nutritional supplements, books, DVDs, resources for better living, health news & more!
ProHealth Health & Wellness Research & News Catalog
Your Purchases Help Fund Ongoing Research
 
 
Search our extensive library for information, solutions & support
Site
Message Board  
Abstracts
Newsletters  
Articles
Products  

FDA Updates Warnings on IBS Drug Lotronex

August 28, 2000

After reports of problems, the FDA is developing a special usage and warning guide for Lotronex, Glaxo Wellcome’s irritable bowel drug.

This decision follows reports that patients on the drug have experienced constipation that has resulted in serious complications, including obstruction, perforation, impaction, toxic megacolon, and secondary ischemia.

Lotronex will be the first prescription drug to have a Medication Guide, which will contain FDA-approved information, written especially for patients so that they will be able to more easily recognize the drug’s risks and take early action to prevent serious harm. Pharmacists will be required to distribute this information with Lotronex.

“Today's actions are an important milestone in enabling consumers, as well as healthcare professionals to better manage the risks that are inherent in even very beneficial drug treatments,” said FDA Commissioner, Dr. Jane E. Henney. “By providing important new safety information about a drug through a Medication Guide to patients, as well as updating the professional labeling, we can better assure that an effective drug can be used safely.”

The new Medication Guide instructs patients to stop taking Lotronex and immediately call their doctor if they become constipated, have new or worsening abdominal pain, or notice blood in their bowel movements.

The updated labeling for physicians will advise that the drug not be prescribed if the patient is currently constipated or has a history of ischemic colitis, intestinal obstruction, Crohn’s Disease, or gastrointestinal perforation.


DISCUSS THIS ARTICLE   (0 existing comments) Post a Comment 
health Research Articles



[ Be the first to comment on this article ]




FDA Updates Warnings on IBS Drug Lotronex Article Tools
Print Page Print Page Email Article Email Article
Discuss Discuss
  Rate This
Most Viewed Articles & Abstracts
Clearing the Fog: Coping with the Cognitive Dysfunction of Fibromyalgia & Chronic Fatigue Syndrome [more]

Chocolate's Potential Health Benefits – and its Effect on Chronic Fatigue Syndrome Patients [more]

What Is Wrong with Artificial Sweeteners? [more]

Flu Shot Pros & Cons [more]

USDA Food Guide Pyramid [more]

Featured Vitamins, Supplements, and Health Products
GABA GABA
Important neurotransmitter in nervous system
Cuddle Ewe™ Sleep Soundly Set - Long Twin Cuddle Ewe™ Sleep Soundly Set - Long Twin
Price includes a $21 domestic shipping charge
CF Support-p CF Support-p
Growth factors support healthy adrenal function for more energy
Cuddle Ewe™ Cotton Flannelette (Full) Cuddle Ewe™ Cotton Flannelette (Full)
Price includes a $7 domestic shipping charge
Healthy Joints Healthy Joints
Top 14 joint nutrients in one formula
Security Enabled AlertSite is a leading provider of Web site monitoring and performance management solutions that help businesses ensure optimum Web experiences for their customers. TrustE Better Business Bureau BizRate Customer Certified (GOLD) Site
ProHealth Vitamin and Supplement SmartSavings Club

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.
ADVANCED MEDICAL LABS   |   WHOLESALE   |   AFFILIATES   |   CONTACT US   |   PRIVACY   |   GLOSSARY   |   CUSTOMER SERVICE   |   RELATED SITES   |   RSS
Email us or Call toll-free 800-366-6056 · Monday through Friday, 7 a.m.-5 p.m. Pacific Time
International Callers dial 001.805.564.3064
Copyright © 2008 ProHealth, Inc.